Godavari Drugs Limited (BOM:530317)

Market Cap	687.01M
Revenue (ttm)	1.06B
Net Income (ttm)	37.02M
Shares Out	7.53M
EPS (ttm)	4.92
PE Ratio	18.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,805
Average Volume	16,495
Open	86.01
Previous Close	88.11
Day's Range	86.01 - 96.86
52-Week Range	69.70 - 115.05
Beta	0.13
RSI	58.75
Earnings Date	Feb 14, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 106
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530317

Financial Performance

In 2024, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.